CompuGroup Medical SE & Co. KGaA

ETR-COP
Deutsche Börse Xetra
Healthcare Health Information Services
Global Rank
#8080
Country Rank
#145
Market Cap
1.36 B
Price
26.25
Change (%)
1.07%
Volume
145,385

CompuGroup Medical SE & Co. KGaA's latest marketcap:

1.36 B

As of 08/02/2025, CompuGroup Medical SE & Co. KGaA's market capitalization has reached $1.36 B. According to our data, CompuGroup Medical SE & Co. KGaA is the 8080th most valuable company globally by market capitalization. Market capitalization, commonly referred to as market cap, represents the total market value of all outstanding shares of a publicly traded company and is often used as a measure of company value.

Market Cap 1.36 B
Revenue (ttm) 1.39 B
Net Income (ttm) 21.14 M
Shares Out 51.73 M
EPS (ttm) 0.41
Forward PE 12.97
Ex-Dividend Date 08/04/2025
Earnings Date 07/31/2025
Market Cap Chart
Data Updated: 08/02/2025

CompuGroup Medical SE & Co. KGaA's yearly market capitalization.

CompuGroup Medical SE & Co. KGaA has seen its market value grow from €989.51 M to €1.17 B since 2014, representing a total increase of 18.47% and an annual compound growth rate (CAGR) of 1.61%.
Date Market Cap(€) Market Cap(USD) Change (%) Global Rank
08/02/2025 €1.17 B $1.36 B 4.14% 8080
12/30/2024 €1.13 B $1.17 B -43.14% 7968
12/29/2023 €1.98 B $2.19 B 5.34% 5310
12/30/2022 €1.88 B $2.01 B -49.6% 5349
12/30/2021 €3.73 B $4.24 B -11.71% 3656
12/30/2020 €4.22 B $5.16 B 37.82% 2753
12/30/2019 €3.06 B $3.44 B 52.92% 3169
12/28/2018 €2 B $2.3 B -26.35% 3665
12/29/2017 €2.72 B $3.26 B 40.51% 3261
12/30/2016 €1.94 B $2.04 B 15.22% 3918

Company Profile

About CompuGroup Medical SE & Co. KGaA

CompuGroup Medical SE & Co. KGaA is a leading provider of e-health services, operating in Germany, Western and Eastern Europe, North America, and internationally. The company specializes in innovative healthcare IT solutions, supporting medical professionals and institutions with cutting-edge technology.

Business Segments

  • Ambulatory Information Systems (AIS)

    Develops and sells management software for registered physicians, medical care centers, and physician networks. This segment offers:

    • Clinical, administrative, and billing solutions
    • Secure internet/intranet platforms for doctor-patient data exchange
    • Data-driven products, medical decision support tools, and digital applications
  • Hospital Information Systems (HIS)

    Provides clinical and administrative solutions for inpatient healthcare, including:

    • Patient administration and resource management
    • Medical documentation, billing, and financial controlling
    • Specialized applications for hospitals, rehabilitation centers, and medical labs
  • Pharmacy Information Systems (PCS)

    Supports pharmacies with administrative and billing software, covering:

    • Medication procurement and inventory management
    • Retail planning and performance monitoring

Company Background

Founded in 1987, CompuGroup Medical SE & Co. KGaA is headquartered in Koblenz, Germany. The company has established itself as a trusted partner in digital healthcare transformation, serving a wide range of medical institutions globally.

Frequently Asked Questions

MarketCapWatch.com ranks all listed companies worldwide, providing unique insights into market capitalization across industries. As one of the most comprehensive ranking platforms, it covers companies of all sizes and sectors.

Ranking

Copyright © 2025. All rights reserved

Important Disclaimer: All content provided on this website, including hyperlinked pages, related applications, forums, blogs, social media accounts, and other platforms ("the Site"), is for general informational purposes only and sourced from third-party providers. We make no guarantees regarding the accuracy, completeness, or timeliness of the content.

None of the information presented constitutes financial, legal, or professional advice. Users should conduct their own research, evaluation, and verification before making any decisions. Investing and trading carry significant risks that may lead to substantial losses. Therefore, we strongly recommend consulting a qualified financial advisor before taking any action.